> There’s been mixed messaging from the administration on GLP-1s Do you have any examples? This is what I've seen: https://www.cnbc.com/2025/11/06/trump-eli-

> There’s been mixed messaging from the administration on GLP-1s Do you have any examples? This is what I've seen: https://www.cnbc.com/2025/11/06/trump-eli-lilly-novo-nordisk-deal-obesity-drug-prices.html https://www.cnbc.com/2025/11/06/trump-eli-lilly-novo-nordisk... Wegovy and Zepbound have not been covered by Medicare for weight loss, “and they’ve only rarely been covered by Medicaid,” Trump said in the Oval Office. “They’ve often cost consumers more than $1,000 per month, some a lot more than that. ... That ends starting today." "“This is the biggest drug in our country, and that’s why this is the most important of all the [most favored nation] announcements we’ve made,” Health and Human Services Secretary Robert F. Kennedy Jr. said during the briefing. “This is going to have the biggest impact on the American people. All Americans, even those who are not on Medicaid, Medicare, are going to be able to get the same price for their drugs, for their GLP-1s.""